CONMED
CNMD
150 hedge funds and large institutions have $1.42B invested in CONMED in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 54 increasing their positions, 50 reducing their positions, and 13 closing their positions.
166% more call options, than puts
Call options by funds: $447K | Put options by funds: $168K
69% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 13
14% more capital invested
Capital invested by funds: $1.25B → $1.42B (+$169M)
6% more funds holding
Funds holding: 142 → 150 (+8)
8% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 50
1.07% less ownership
Funds ownership: 100.81% → 99.74% (-1.1%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AP
AHL Partners
London,
United Kingdom
|
+$7.55M |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$6.24M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.95M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$4.22M |
| 5 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
+$4.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$9.99M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.14M |
| 3 |
KAM
Krensavage Asset Management
New York
|
-$6.42M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$4.03M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.93M |
CNMD Hedge Fund Activity: Q2 2017 in Review
150 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2017, worth a combined $1.42B — up 14% from $1.25B a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CNMD positions and 13 closed out — a net gain of 9 holders — while 54 added to existing stakes and 50 trimmed.
The largest buyer was AHL Partners, adding an estimated $7.55M. The largest seller was Capital Research Global Investors, cutting an estimated $9.99M.
- 150 institutional investors held CONMED (CNMD) as of Q2 2017, up from 142 in Q1 2017.
- Funds reported $1.42B of CONMED stock for Q2 2017, up 14% quarter-over-quarter.
- 22 funds opened new CONMED positions in Q2 2017 and 13 closed out, a net change of +9 holders.
- The largest CONMED buyer in Q2 2017 was AHL Partners, an estimated $7.55M added.
- The largest CONMED seller in Q2 2017 was Capital Research Global Investors, an estimated $9.99M sold.
Based on aggregated 13F filings for Q2 2017.